Subdural Hematoma Clinical Trial
Official title:
Evaluation of One Burr Hole Evacuation for Subdural Hematoma
To evaluate the outcome of one burrhole evacuation for subdural hematoma and it has the same result of traditional two burrhole
| Status | Not yet recruiting |
| Enrollment | 35 |
| Est. completion date | October 1, 2024 |
| Est. primary completion date | July 1, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Patients with subdural hematoma either unilateral or bilateral - fit for surgery - Chronic SDH - Subacute SDH - Age: patients older than 18 years old - SEX: Both sex Exclusion Criteria: - Patients unfit for surgery - Acute SDH - subdural hyroma - subdural empyema - patient treated conservatively |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Mohammed lotfi abdelkareem | Assiut | |
| Egypt | Mohammed lotfi abdelkareem | Minya | Malawi |
| Lead Sponsor | Collaborator |
|---|---|
| Assiut University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | ClinicalEvaluation of evacuation for subdural hematoma by one burrhole | glasgo coma scale,
neurological deficit, clinical symptoms (seizures) . |
72 hours post operative | |
| Secondary | Radiological evaluation for outcome | Nearly gross total evacuation according to confirmation by postoperative CT brain | 72 hours post operative |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04402632 -
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
|
N/A | |
| Completed |
NCT03496545 -
Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury
|
Phase 1/Phase 2 | |
| Terminated |
NCT05472766 -
Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma
|
N/A | |
| Not yet recruiting |
NCT06052124 -
Augmented Reality for Subdural Drain Placement
|
N/A | |
| Completed |
NCT02368366 -
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
|
N/A | |
| Terminated |
NCT01463878 -
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
|
Phase 4 | |
| Completed |
NCT02618382 -
A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
|
Phase 4 | |
| Recruiting |
NCT04923984 -
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
|
N/A | |
| Completed |
NCT03153150 -
Start or STop Anticoagulants Randomised Trial (SoSTART)
|
Phase 3 | |
| Completed |
NCT04270955 -
Dartmouth Middle Meningeal Embolization Trial (DaMMET)
|
N/A | |
| Recruiting |
NCT06067750 -
Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
|
||
| Not yet recruiting |
NCT05713630 -
The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma
|
Phase 3 | |
| Withdrawn |
NCT01605357 -
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04500795 -
Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma
|
N/A | |
| Recruiting |
NCT04170582 -
Patient Registry for Patients With Chronic Subdural Hematoma
|
||
| Recruiting |
NCT05649904 -
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
|
N/A | |
| Recruiting |
NCT04211233 -
Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE)
|
N/A |